S
Samil Pharmaceutical Co Ltd
KRX:000520
Samil Pharmaceutical Co Ltd
KRX:000520
Price:
10 340
KRW
3.5%
Market Cap:
₩224.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Samil Pharmaceutical Co Ltd
KRX:000520
|
KR |
|
O
|
OneConnect Financial Technology Co Ltd
NYSE:OCFT
|
CN |
|
Basic Chemical Industries Company SJSC
SAU:1210
|
SA |
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
HK |
|
Y
|
Yorkey Optical International (Cayman) Ltd
HKEX:2788
|
HK |
|
C
|
Centrus Energy Corp
AMEX:LEU
|
US |
|
P
|
Pacific Pipe PCL
SET:PAP
|
TH |
|
N
|
NC Housing PCL
SET:NCH
|
TH |
Relative Value
The Relative Value of one Samil Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 10 340 KRW, Samil Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Samil Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Samil Pharmaceutical Co Ltd Competitors
Samil Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
S
|
Samil Pharmaceutical Co Ltd
KRX:000520
|
219.5B KRW | 1 | -8.1 | -86.7 | -20.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
